AdCom Meetings
FDA Advisory Committee (AdCom) meetings convene independent expert panels to review drug safety and efficacy data. The committee's vote, while non-binding, predicts FDA approval 75-80% of the time.
0 adcom meetings tracked. Event dates and source records are shown with their available source context.
No adcom meetings tracked for this period. Check back soon.
Frequently asked questions
What is an FDA Advisory Committee (AdCom) meeting?
An AdCom convenes an independent panel of outside experts to review a drug's safety and efficacy data and vote on a recommendation to the FDA.
Is an AdCom vote binding on the FDA?
No — the committee's vote is advisory, but historically it predicts the FDA's final decision roughly 75-80% of the time.
When are AdCom meeting dates announced?
The FDA typically publishes Advisory Committee meeting dates in the Federal Register weeks in advance; BioSniper tracks them as they are scheduled.
Learn more
How to Read FDA Advisory Committee (AdCom) Meeting Results
Learn how FDA Advisory Committee meetings work, how to interpret voting results, and what AdCom outcomes mean for biotech stock prices.
What Is PDUFA? A Complete Guide for Biotech Investors
Understand PDUFA dates, how the FDA review process works, and why PDUFA action dates are the most important catalysts in biotech investing.
FDA Complete Response Letters (CRLs): What They Mean for Biotech Investors
Learn what a Complete Response Letter is, why the FDA issues CRLs, how companies respond, and what CRL outcomes mean for biotech stock prices and timelines.
Key terms
From catalyst type to protocol condition
Decide when this event type should matter
Set the timing, confidence, company, drug, trial, and financing conditions that must hold before this catalyst changes a decision.